09939.HK
Kintor Pharmaceutical Limited
HKSE · Healthcare · Biotechnology · CN
HKD 1.35
−6.25%Margins
Gross margin
12.6%
EBITDA margin
-205.2%
EBIT margin
-256.1%
Net margin
-244.4%
FCF margin
-128.5%
-173.6%
Return on equity
-59.5%
Return on assets
-81.8%
Return on invested capital
0.24x
Asset turnover
-HKD 176.6M
Cash from operations
HKD 0.08
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026